Alteogen Inc

Common Name

Alteogen

Country

South Korea

Sector

Healthcare

Industry

Biotechnology

Employees

155

Ticker

196170

Exchange

KOREA EXCHANGE

Website

www.alteogen.com

Description

ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth horm... Show more

Income Statement Balance Sheet Group Entities

Alteogen's Financial Statements Preview

Below are the financial statements of Alteogen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of KRW	2024 as of 2024-12-31	2024 as of Not Specified	2023 as of 2023-12-31	2023 as of Not Specified	2022 as of 2022-12-31	2022 as of Not Specified
Current assets	211.78^a	211.78^a	144.08^a	143.01^a	145.1^a	143.52^a
Cash and cash equivalents	18.99^a	-	30.2^a	1.07^a	45.83^a	1.57^a
Short-term financial instruments	165.26^a	-	55.09^a	112.02^a	81.71^a	100.39^a
Trade and other current receivables	20.22^a	-	16.73^a	1.15^a	8.77^a	20.29^a
Current contract assets	2.24^a	-	13.93^a	19.29^a	0^a	27.24^a
Current income tax assets	0.9^a	-	0.73^a	89.33^a	0.62^a	47.3^a
Current financial assets, mandatorily measured at fair value through profit or loss	0^a	-	5.08^a	2.25^a	0^a	5.56^a
Current held-to-maturity financial assets	1^a	-	20.24^a	256.1^a	0^a	245.49^a
Other current assets	2.21^a	-	1.01^a	100.42^a	0.82^a	94.31^a
Current inventories	0.96^a	-	1.07^a	7.84^a	1.57^a	5.8^a
Total non-current assets or disposal groups classified as held for sale or distribution to owners	0^a	-	0^a	108.26^a	5.77^a	100.11^a
Non-current assets	197.23^a	-	112.02^a	148.11^a	100.39^a	148.76^a
Long-term financial instruments	0^a	-	0^a	26.51^a	20.29^a	26.21^a
Non-current financial assets, mandatorily measured at fair value through profit or loss	2.65^a	-	1.15^a	106.99^a	0^a	104.56^a
Property, plant and equipment	19.25^a	-	18.8^a	14.62^a	26.96^a	17.99^a
Right-of-use assets	0.37^a	-	0.49^a	-0.27^a	0.29^a	-3.38^a
Goodwill, gross	0.11^a	-	0.11^a	147.84^a	0.11^a	145.38^a
Intangible assets other than goodwill	112.03^a	-	89.22^a	-	47.19^a	-
Other non-current financial assets	0.49^a	-	0.4^a	-	0.74^a	-
Other non-current assets	1.14^a	-	1.85^a	-	4.82^a	-
Deferred tax assets	61.19^a	-	0^a	-	0^a	-
Total assets	409.01^a	-	256.1^a	-	245.49^a	-
Current liabilities	129.19^a	-	100.42^a	-	94.31^a	-
Trade and other current payables	31.11^a	-	5.35^a	-	9.87^a	-
Current borrowings	5^a	-	0^a	-	3.13^a	-
Short-term trade payables	10.04^a	-	1.01^a	-	0.16^a	-
Current contract liabilities	11.78^a	-	0^a	-	2.42^a	-
Current lease liabilities	0.25^a	-	0.29^a	-	0.16^a	-
Quick assets	-	210.83^a	-	-	-	-
Inventories	-	0.96^a	-	-	-	-
Non-current assets	-	197.23^a	-	-	-	-
Investment assets	-	2.65^a	-	-	-	-
Property, plant and equipment	-	19.62^a	-	-	-	-
Intangible assets	-	112.14^a	-	-	-	-
Other non-current assets	-	62.82^a	-	-	-	-
Total assets	-	409.01^a	-	-	-	-
Current liabilities	-	129.19^a	-	-	-	-
Non-current liabilities	-	5.74^a	-	-	-	-
Total liabilities	-	134.92^a	-	-	-	-
Equity attributable to owners of the parent	-	273.59^a	-	-	-	-
Share capital	-	26.66^a	-	-	-	-
Other paid-in capital	-	170.06^a	-	-	-	-
Consolidated retained earnings	-	76.87^a	-	-	-	-
Non-controlling interests	-	0.5^a	-	-	-	-
Total equity	-	274.09^a	-	-	-	-

Download Data

Verified Sources Behind Alteogen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alteogen’s data sources below and access millions more through our Disclosure Search.

a. Alteogen's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Alteogen Inc

Alteogen's Financial Statements Preview

Verified Sources Behind Alteogen’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Cytokinetics Inc

Camurus AB

Verona Pharma PLC

Arcellx Inc

Kymera Therapeutics Inc

Blueprint Medicines Corp